1,126
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hiten RH Patel. (2014) Foreword. Expert Review of Anticancer Therapy 14:11, pages 1251-1252.
Read now

Articles from other publishers (5)

Meir Weksler, Avi Simon, Robert E. Lenkinski, Hagar Landsman, Haim Matzkin, Nicola Mabjeesh & Ilan Leibovitch. (2023) A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer. Diagnostics 13:3, pages 424.
Crossref
Vinit Singh Baghel, Sapnita Shinde, Vibha Sinha, Vineeta Dixit, Atul Kumar Tiwari, Saurabh Saxena, Naveen Kumar Vishvakarma, Dhananjay Shukla & Prashant Bhatt. 2023. Transcription and Translation in Health and Disease. Transcription and Translation in Health and Disease 287 324 .
Pedro Bargão Santos, Hitendra Patel, Rui Henrique & Ana Félix. (2020) Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?. World Journal of Clinical Oncology 11:2, pages 43-52.
Crossref
Jorge Torres-Ferreira, João Ramalho-Carvalho, Antonio Gomez, Francisco Duarte Menezes, Rui Freitas, Jorge Oliveira, Luís Antunes, Maria José Bento, Manel Esteller, Rui Henrique & Carmen Jerónimo. (2017) MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors. Molecular Cancer 16:1.
Crossref
Pedro Costa-Pinheiro, Diana Montezuma, Rui Henrique & Carmen Jerónimo. (2015) Diagnostic and prognostic epigenetic biomarkers in cancer. Epigenomics 7:6, pages 1003-1015.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.